Crescent Biopharma, Inc.

CBIO · Healthcare · Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States

Crescent Biopharma, Inc. (CBIO), in the Healthcare sector, has 5 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 2 purchases and 3 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Sep 18 and filed Sep 18. The most active filer was Joshua T Brumm with 2 filings.

Add to watchlist

Filings, ttm

2 buys · 3 sells

Traders, ttm

3 insiders

Volume, ttmiDollar value disclosed in the window

$31.9M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 18

Filed Sep 18

ADViAverage daily dollar volume

$5.9M

market data

Share price · 12M

$16.25 (+24.0%)

Adjusted for splits and dividends.

Volume by month

Buys $30.6M Sells $1.3M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Joshua T Brumm Chief Executive Officer 2 filings FL Fairmount Funds Management LLC Director 2 filings JM

Jonathan McNeill President and COO 1 filing

Recent filings

Joshua T BrummSALE Chief Executive Officer $131K
7,837 sh × $16.71
Exec Sep 18
Filed Sep 18 · 4:02 PM ET Fairmount Funds Management LLCPURCHASE Director $12.4M
853,450 sh × $14.50
Exec Jul 16
Filed Jul 20 · 5:30 PM ET Joshua T BrummSALE Chief Executive Officer $761K
42,305 sh × $17.99
Exec Jun 22
Filed Jun 23 · 5:30 PM ET Jonathan McNeillSALE President and COO $370K
20,549 sh × $17.99
Exec Jun 22
Filed Jun 23 · 5:30 PM ET Fairmount Funds Management LLCPURCHASE Director $18.2M
1,360,000 sh × $13.41
Exec Dec 4 2025
Filed Dec 8 2025 · 4:30 PM ET